[PLX] QoQ Quarter Result on 31-Mar-2017 [#Q1]

Stock
[PLX] Protalix BioTherapeutics, Inc.
Announcement Date
10-May-2017
Financial Year
2017
Quarter
31-Mar-2017 [#Q1]
Profit Trend
QoQ- -2,154.12%
YoY- -587.93%
Quarter Report
PLX's Result
PLX's Financial Summary
View:
Show?
Quarter Result
31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 CAGR
Revenue 2,469 7,526 6,358 2,889 2,081 4,670 1,769 24.81%
PBT -15,141 -11,437 450 -59,148 -2,624 -7,290 -10,736 25.68%
Tax 916 8 3,045 2,087 -189 268 213 163.74%
NP -15,141 -11,437 450 -59,148 -2,624 -7,290 -10,853 24.77%
Tax Rate - - -676.67% - - - - -
Total Cost 17,610 18,963 5,908 62,037 4,705 11,960 12,622 24.78%
Ratio Analysis
31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 CAGR
NP Margin -613.24 -151.97 7.08 -2,047.35 -126.09 -156.10 -613.51 -0.02%
Per Share
31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 CAGR
EPS -1.08 -0.86 0.04 -4.75 -0.21 -0.07 -0.11 356.61%
EPS Diluted -1.04 -0.86 -0.60 -4.75 -0.21 -0.07 -0.11 345.29%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.